FollowMyHealth Patient Portal

Jeffrey D. Bradley, MD

S. Lee Kling Professor, Radiation Oncology
Chief, Thoracic Service
Director, S. Lee Kling Center for Proton Therapy

Specialty Areas

Radiation Oncology
Thoracic Oncology
Lung Cancer
Esophageal Cancer
Stereotactic Body Radiation Therepy
Proton Therapy

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes-Jewish Hospital
St. Louis Children's Hospital

Areas of Clinical Interest

Radiation oncology, lung cancer, thoracic cancer, breast cancer,  stereotactic body radiotherapy, esophageal cancer, PET, proton therapy

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Barnes-Jewish West County Hospital 
Siteman Cancer Center
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141
Phone: 314-747-7222

Office Phone: 314-996-3335
Fax: 314-996-3338

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Floor: LL
Office Phone: 314-747-7236
Additional Phone: 314 747-7236
Fax: 314-362-8521

Education

Education

Fellowship: Am. Soc.Therapuetic Radiology and Onc, Dept Radiation & Cellular Oncology, The Univ Chicago Med Ctr 1998
Medical Degree: University Of Arkansas 1993
Residency: Radation Oncology, University of Chicago Medical Center 1998

Publication & Research

Publication & Research

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC): NRG Oncology RTOG 0937.
Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD
J Thorac Oncol. 2017 Jun 22; pii: S1556-0864(17)30468-9. doi: 10.1016/j.jtho.2017.06.015.

PMID:
    28648948
    [PubMed - as supplied by publisher]
Related citations


Randomized Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-small Cell Lung Cancer: NRG Oncology RTOG 0839.
Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD
J Thorac Oncol. 2017 Jun 16; pii: S1556-0864(17)30459-8. doi: 10.1016/j.jtho.2017.06.007.

PMID:
    28629896
    [PubMed - as supplied by publisher]
Related citations


Athermal synchronization of laser source with WDM filter in a silicon photonics platform.
Li N, Su Z, Purnawirman, Salih Magden E, Poulton CV, Ruocco A, Singh N, Byrd MJ, Bradley JDB, Leake G, Watts MR
Appl Phys Lett. 2017 May 22; 110(21)211105. doi: 10.1063/1.4984022.

PMID:
    28611487
    [PubMed - in process]
Related citations


Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.
Jeong J, Oh JH, Sonke JJ, Belderbos JSA, Bradley JD, Fontanella AN, Rao SS, Deasy J
Clin Cancer Res. 2017 May 24; pii: clincanres.3277.2017. doi: 10.1158/1078-0432.CCR-16-3277.

PMID:
    28539466
    [PubMed - as supplied by publisher]
Related citations


Challenging Situations for Lung SBRT.
Przybysz D, Bradley JD
J Thorac Oncol. 2017 Jun; 12(6)916-918. doi: 10.1016/j.jtho.2017.04.007.

PMID:
    28532561
    [PubMed - in process]
Related citations


Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.
Stinchcombe TE, Zhang Y, Vokes EE, Schiller JH, Bradley JD, Kelly K, Curran WJ Jr, Schild SE, Movsas B, Clamon G, Govindan R, Blumenschein GR, Socinski MA, Ready NE, Akerley WL, Cohen HJ, Pang HH, Wang X
J Clin Oncol. 2017 May 11; JCO2016714758. doi: 10.1200/JCO.2016.71.4758.

PMID:
    28493811
    [PubMed - as supplied by publisher]
Related citations


Wavelength division multiplexed light source monolithically integrated on a silicon photonics platform.
Purnawirman, Li N, Magden ES, Singh G, Moresco M, Adam TN, Leake G, Coolbaugh D, Bradley JDB, Watts MR
Opt Lett. 2017 May 1; 42(9)1772-1775. doi: 10.1364/OL.42.001772.

PMID:
    28454157
    [PubMed - in process]
Related citations


High-power thulium lasers on a silicon photonics platform.
Li N, Purnawirman P, Su Z, Salih Magden E, Callahan PT, Shtyrkova K, Xin M, Ruocco A, Baiocco C, Ippen EP, Kärtner FX, Bradley JD, Vermeulen D, Watts MR
Opt Lett. 2017 Mar 15; 42(6)1181-1184. doi: 10.1364/OL.42.001181.

PMID:
    28295078
    [PubMed - in process]
Related citations


Reply to D. Ball et al.
Chun SG, Hu C, Bradley JD
J Clin Oncol. 2017 May 1; 35(13)1493-1494. doi: 10.1200/JCO.2016.71.5755.

PMID:
    28068179
    [PubMed - in process]
Related citations


Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD
J Clin Oncol. 2017 Jan; 35(1)56-62.

PMID:
    28034064
    [PubMed - in process]
Related citations


Ultra-compact and low-threshold thulium microcavity laser monolithically integrated on silicon.
Su Z, Li N, Salih Magden E, Byrd M, Purnawirman P, Adam TN, Leake G, Coolbaugh D, Bradley JD, Watts MR
Opt Lett. 2016 Dec 15; 41(24)5708-5711. doi: 10.1364/OL.41.005708.

PMID:
    27973495
    [PubMed - in process]
Related citations


Optimal treatment of unresectable stage III non-small cell lung cancer.
Bradley JD
Clin Adv Hematol Oncol. 2016 Nov; 14(11)853-855.

PMID:
    27930635
    [PubMed - indexed for MEDLINE]
Related citations


Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505).
Gerber DE, Urbanic JJ, Langer C, Hu C, Chang IF, Lu B, Movsas B, Jeraj R, Curran WJ, Bradley JD
Clin Lung Cancer. 2017 May; 18(3)333-339. doi: 10.1016/j.cllc.2016.10.009.

PMID:
    27923550
    [PubMed - in process]
Related citations


Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, Fergus S, Trovo M, Bradley JD, Robinson CG
J Thorac Oncol. 2017 Feb; 12(2)293-301. doi: 10.1016/j.jtho.2016.09.134.

PMID:
    27743888
    [PubMed - in process]
Related citations


Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials.
Landewé RB, Connell CA, Bradley JD, Wilkinson B, Gruben D, Strengholt S, van der Heijde D
Arthritis Res Ther. 2016 Sep 23; 18(1)212.

PMID:
    27663201
    [PubMed - as supplied by publisher]
Related citations


Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ, Redman MW, Manola JB, Schilsky RL, Cohen HJ, Bradley JD, Adjei AA, Gandara D, Ramalingam SS, Vokes EE
J Clin Oncol. 2016 Sep 19; pii: JCO677088.

PMID:
    27646951
    [PubMed - as supplied by publisher]
Related citations


Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis.
Jansen JP, Vieira MC, Bradley JD, Cappelleri JC, Zwillich SH, Wallenstein GV
BMC Musculoskelet Disord. 2016 Aug 18; 17(1)348. doi: 10.1186/s12891-016-1195-4.

PMID:
    27538585
    [PubMed - in process]
Related citations


Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Salahudeen AA, Patel MI, Baas P, Curran WJ, Bradley JD, Gandara DR, Goss GD, Mok TS, Ramalingam SS, Vokes EE, Malik SM, Wakelee HA
Clin Lung Cancer. 2017 Jan; 18(1)5-12. doi: 10.1016/j.cllc.2016.06.007.

PMID:
    27473736
    [PubMed - in process]
Related citations


Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.
Eaton BR, Pugh SL, Bradley JD, Masters G, Kavadi VS, Narayan S, Nedzi L, Robinson C, Wynn RB, Koprowski C, Johnson DW, Meng J, Curran WJ Jr
J Natl Cancer Inst. 2016 Sep; 108(9)pii: djw034. doi: 10.1093/jnci/djw034.

PMID:
    27206636
    [PubMed - in process]
Related citations


Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC.
Giaddui T, Chen W, Yu J, Lin L, Simone CB 2nd, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O'Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y
Radiat Oncol. 2016 May 4; 1166. doi: 10.1186/s13014-016-0640-8.

PMID:
    27142674
    [PubMed - indexed for MEDLINE]
Related citations